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Abstract
A 50 year old woman with a 10-year history of systemic lupus erythematosus (SLE) and
intermittent low-dose cyclophosphamide therapy developed a palpable mass at the periphery of
her left breast. Ultrasound guided core biopsy revealed a spindle cell neoplasm characterized on
final pathology as a low grade leiomyosarcoma.
Background
Sarcomas of the breast are rare entities and comprise only
1% of malignancies [1]. Leiomyosarcomas represent 2.5–
6% of these and usually present as enlarging palpable
masses [2]. The limited number of cases treated at any one
institution has hampered making specific recommenda-
tions regarding surgery and adjuvant treatments for this
pathological entity. As with other sarcomas the mainstay
of treatment is resection with or without adjuvant radio-
therapy.
Case Presentation
A 50 year old woman detected a mass in her left breast on
self-exam (figure 1). Diagnostic mammography showed a
well-circumscribed, oval mass which was hypoechoic on
ultrasound and measured 3.5 × 1.4 × 2.8 cm. Family his-
tory of breast or ovarian cancer was not present. She expe-
rienced menarche at the age of 10, and early onset of
menopause at age 40. She is gravida 1 and para 0, and
denied past use of oral contraceptives or hormonal
replacement therapy. On clinical breast exam the patient
had a well circumscribed mass in her left upper outer
quadrant and no regional lymphadenopathy. She then
underwent ultrasound guided core biopsy which revealed
a spindle cell neoplasm.
The patient's medical history was significant for SLE, dia-
betes mellitus type 2, rheumatoid arthritis, and asthma.
Her medications include cyclophosphamide, accolade,
cimetidine, etodolac, tramadol, halcion, flexeril, advair,
albuterol, iron supplements, benadryl, and zofran. Her
cyclophosphamide exposure was intermittent over a ten
year history. The patient's past surgical history was signif-
icant for a tubal ligation and appendectomy. She currently
works as an office manager and denies alcohol or tobacco
use.
The diagnosis of spindle cell neoplasm raised the possibil-
ity of metaplastic carcinoma, a subtype of invasive ductal
carcinoma; therefore a nodal staging procedure with sen-
tinel lymph node biopsy was incorporated into the surgi-
cal plan. Lumpectomy was considered as there were no
definite contraindications to radiotherapy with this type
of SLE. However, concerns regarding cosmetic outcome
and radiation tolerance in collagen vascular disease pre-
senting with skin involvement, swayed the patient toward
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mastectomy. A tissue expander was placed at time of mas-
tectomy. Unfortunately the postoperative course was
complicated by wound infection and loss of expander.
Final pathology revealed a 3.2 cm tumor comprised of
spindle cells with abundant eosinophilic cytoplasm
arranged in fascicles, with marked pleomorphism with no
epithelial glandular elements (Figure 2). The tumor cells
stained positive for desmin, smooth muscle actin, and cal-
ponin although negative for S100, HMB45, CKMIX, and
p63: defining this lesion as a leiomyosarcoma. Metastatic
workup with CT scan of the chest, abdomen, and pelvis
were negative. Eleven months after her mastectomy the
patient continues to do well and has no evidence of recur-
rent disease.
Discussion
Leiomyosarcomas of the breast are rare neoplasms that
either arise from the smooth muscle cells lining blood ves-
sels or from stromal mesenchymal cells [2,3]. Breast sar-
comas are treated by the same principles used in other
sarcomas. Thus, wide local excision/lumpectomy or mas-
tectomy with or without radiotherapy are used [4]. Lym-
Breast Imaging Figure 1
Breast Imaging. (A) Digital mammogram (B) ultrasound showing dominant mass in the upper central portion of the breast.
 
Microphotograph of leiomyosarcoma Figure 2
Microphotograph of leiomyosarcoma. Hematoxylin and 
eosin stain demonstrates a highly cellular, pleomorphic, and 
spindle shaped tumor with few mitotic figures (40×).Publish with BioMed Central    and   every 
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phatic spread and nodal metastasis are not features
associated with these neoplasms. Axillary nodal metasta-
sis occurs in less than 10% of breast sarcomas, making
sentinel lymph node biopsy or axillary lymph node dis-
section unnecessary [5]. In this case nodal staging was per-
formed at the time of definitive surgery because the core
biopsy findings (spindle cells) were interpreted as poten-
tially representing a metaplastic breast cancer.
Cyclophosphamide is an akylating agent used commonly
for the treatment of malignancies as well as for autoim-
mune disorders [6]. Cyclophosphamide has been linked
to secondary cancers, namely bladder cancer, osteosar-
coma, and leukemia [7]. Therefore it is unclear whether
this type of exposure could have been a contributing fac-
tor to the development of this breast leiomyosarcoma.
Patients with collagen vascular diseases have increased
late toxicity with radiotherapy, specifically increased
fibrosis and thus breast irradiation is not recommended
[8]. Therefore, careful consideration should be given to
the potential complications of radiotherapy in patients
with similar autoimmune disorders. Lastly postoperative
infection is a known complication of tissue expander
placement and occurs in approximately 2% of cases with
associated loss [9].
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